FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2025448304> ?p ?o ?g. }

• W2025448304 endingPage "80" @default.
• W2025448304 startingPage "71" @default.
• W2025448304 abstract "Journal of Clinical Pharmacy and TherapeuticsVolume 12, Issue 2 p. 71-80 Free Access THERAPEUTIC PROGRESS–REVIEW XXIV ARE WE MAKING PROGRESS? THE TREATMENT OF PEPTIC ULCER DISEASE BY CONTROL OF GASTRIC ACIDITY P. I. Reed, Corresponding Author P. I. Reed Wexham Park Hospital, Slough SL2 4HL, U.K.Consultant Physician and Gastroenterologist, Wexham Park Hospital, Slough SL2 4HL, U.K.Search for more papers by this authorR. L. McIsaac, R. L. McIsaac *Department of Gastroenterology, Glaxo Group Research, Greenford UB6 OHE, U.K.Search for more papers by this author P. I. Reed, Corresponding Author P. I. Reed Wexham Park Hospital, Slough SL2 4HL, U.K.Consultant Physician and Gastroenterologist, Wexham Park Hospital, Slough SL2 4HL, U.K.Search for more papers by this authorR. L. McIsaac, R. L. McIsaac *Department of Gastroenterology, Glaxo Group Research, Greenford UB6 OHE, U.K.Search for more papers by this author First published: April 1987 https://doi.org/10.1111/j.1365-2710.1987.tb00511.xAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL REFERENCES 1 Lam, S.K. (1984) Pathogenesis and pathophysiology of duodenal ulcer. Climics in Gaszroenterology, 13, 447– 472. 2 Konturek, S.J. (1983) Pharmacologic control of gastric acid secretion in peptic ulcer. Moum Sinai Journal of Medicine, 50, 457– 467. 3 McNulty, C.A.M. & Wise, R. (1985) Gastric microflora. British Medical Journal, 291, 367– 368. 4 Wormsley, K.G. (1983) Duodenal ulcer: does pathophysiology equal aetiology Gut, 24, 775– 780. 5 Blum, A.L., Siewert, J.R. & Halle, F. (1978) Ulcer therapy with cimetidine. Deutsche Medizinische Wochenschrift, 103, 135– 139. 6 Wormsley, K.G. (1981) Short-term treatment of duodenal ulceration. In: Cimevidine in the Eighties (ed. J. H. Baron), pp. 3– 8. Churchill Livingstone, Edinburgh . 7 Howden, C.W., Jones, D.B. & Hunt, R.H. (1985) Effect of H2-receptor antagonist (H2RA) in gastric ulcer (GU) is independent of anti secretory effect. Gut, 26, A1116. 8 Jones, D.B. & Hunt, R.H. (1986) The drug treatment of duodenal ulcer: physiological considerations in the choice of therapy. Australia and New Zealand Journal of Medicine, 16, 263– 267. 9 Walt, R. (1986) Twenty-four hour intragastric acidity analysis for the future. Gut, 27, 1– 9. 10 Blum, A.L. (1985) Therapeutic approach to ulcer healing. American Journal of Medicine 79 (2C), 8– 14. 11 Sonnenberg, A. (1985) Comparison of different strategies for treatment of duodenal ulcer. British Medical Journal, 290, 1185– 1187. 12 Peterson, W.L. & Richardson, C.T. (1983) Pharmacology and side-effects of drugs used to treat peptic ulcer. In: Gastrointestinal Disease: Pathophysiology, Diagnosis and Management. (eds. M. H. Slesinger & J. S. Fordtran) pp. 708– 725, W. B. Saunders Co, Philadelphia . 13 Wicks, A. (1986) Peptic ulceration. Mims Magazine, September 1, i– xi. 14 Ippoliti, A., Elashoff, J., Valenzuela, J. et al. (1983) Recurrent ulcer after successful treatment with cimetidine or antacid. Gastroenterology, 85, 875– 880. 15 Fedeli, G., Anti, M., Rapaccini, G.L., De Vitis, I., Butti, A. & Civello, I.M. (1979) A controlled study comparing cimetidine treatment to an intensive antacid regimen in the therapy of uncomplicated duodenal ulcer. Digestive Diseases and Science, 24, 758– 762. 16 F. Halter (ed) (1982) Antacids in the Eighties. Urban & Schwarzenberg, Munich . 17 Rhodes, J. (1982) Side-effects of antacid treatment. In: Antacids in the Eighties (ed. F. Halter), pp. 99– 102. Urban & Schwarzenberg, Munich . 18 Dammann, H.G., Ergenzinger, K., Kistner, S., Walter, T.A., Muller, P. & Simon, B. (1984) Effects of histamine H2-receptor antagonists and other agents on intragastric acidity and acid secretion. In: Ranitidine: Therapeutic Advances (eds. J. J. Misiewicz & J. R. Wood), pp. 126– 139. Excerpta Medica, Amsterdam . 19 Etienne, A., Fimmel, C.J., Bron, B.A., Loizeau, E. & Blum, A.L. (1985) Evaluation of pirenzepine on gastric acidity in healthy volunteers using ambulatory 24 hour intragastric pH monitoring. Gut, 26, 241– 245. 20 Mahachai, V., Jamali, F., Reilly, P. & Thomson, A.B.R. (1984). Pharmacokinetics and effect of pirenzepine on gastric acid secretion in duodenal ulcer disease. Gastroenterology, 86, 1171. 21 Carmine, A.A. & Brogden, R.N. (1985) Pirenzepine: a review of its pharmacodynamic efficacy in peptic ulcer disease and other allied disease. Drugs, 30, 85– 126. 22 Paoluzi, P., Ricotta, G., Iafrancesco, G., Zaccardelli, E., Ripoli, F. & Carratu, R. (1982) Pirenzepine and cimetidine in the treatment of duodenal ulcer: results of a double-blind trial. Italian Journal of Gastroenterology, 14, 225– 227. 23 Brogden, R.N., Carmine, A.A., Heel, R.C., Speight, T.M. & Avery, G.S. (1982) Ranitidine: a review of its pharmacology and therapeutic use in peptic ulcer disease and other allied diseases. Drugs, 24, 267– 303. 24 Richards, D.A. (1983) Comparative pharmacodynamics and pharmacokinetics of cimetidine and ranitidine. Journal of Clinical Gastroenterology, 5 (1), 81– 93. 25 Lewis, J.H. (1986) Summary of the 30th meeting of the food and drug administration gastrointestinal drugs advisory committee. American Journal of Gastroenterology, 81, 495– 498. 26 Lee, F.I., Reed, P.I., Crowe, J.P., McIsaac, R.L. & Wood, J.R. (1986) Acute treatment of duodenal ulcer: a multicentre study to compare ranitidine 150 mg twice daily with 300 mg once at night. Gut, 27, 1091– 1095. 27 Simon, B., Bianchi-Porro, G., Cremer, M. et al. (1986) A single night-time dose of ranitidine 300 mg versus ranitidine 150mg twice daily in the acute treatment of duodenal ulcer: a European multicentre trial. Journal of Clinical Gastroenterology, 893, 367– 370. 28 Brater, D.C., Peters, M.N., Eshelman, F.N. & Richardson, C.T. (1982) Clinical comparison of cimctidine and ranitidine. Clinical Pharmacology and Therapeutics, 32, 484– 489. 29 Walt, R.P., Male, P.J., Rawlings, J., Hunt, R.H., Milton-Thompson, G.J. & Misiewicz, J.J. (1981) Comparison of the effects of ranitidine, cimetidine and placebo on the 24 hour intragastric acidity and nocturnal acid secretion in patients with duodenal ulcer. Gut, 22, 49– 54. 30 Gledhill, T., Howard, O.M., Buck, M., Paul, A. & Hunt, R.H. (1983) Single nocturnal dose of an H2-receptor antagonist for the treatment of duodenal ulcer. Gut, 24, 904– 908. 31 Jensen, R.T., Collen, M.J., Pandol, S.J. et al. (1983) Cimetidine-induced impotence and breast changes in patients with gastric hypersecretory states. New England Journal of Medicine, 308, 883– 887. 32 Powell, J.R. & Donn, K.H. (1984) Histamine-H2-antagonist drug interactions in perspective: mechanistic concepts and clinical implications. American Journal of Medicine, 77 (5B), 57– 84. 33 Meyrick Thomas, J. & Misiewicz, G. (1984) Histamine-H2-receptor antagonists in the short and long-term treatment of duodenal ulcer. Clinics in Gastroenterology, 13, 501– 541. 34 Jones, D.B. & Yeomans, N.D. (1985) Cimetidine versus ranitidine in short-term healing of duodenal ulcers. Gut, 26, 642. 35 Laverdant, C. (1983) A multicentre international comparative trial of ranitidine and cimetidine in short-term treatment of duodenal ulcer. Gastroenterologie Clinique et Biologique, 7, 480– 486. 36 Cortot, A., Amar, H., Palacci, A., Pappo, M. & Paris, J.C. (1986) A comparison of ranitidine (150 mg × 2) versus cimetidine (400 mg × 2) in the treatment of acute duodenal ulcer. Gastroenterology, 90, 1381. 37 Elashoff, J. (1978) Combining results of clinical trials. Gastroenterology, 75, 1170– 1172. 38 Howden, C.W., Jones, D.B. & Hunt, R.H. (1985) Nocturnal doses of H2-receptor antagonists for duodenal ulcer. Lancet, i, 647– 648. 39 Colin-Jones, D.G. (1982) Review of the total data on the acute treatment of peptic ulceration with ranitidine. In: Ranitidine, The New Selective H2-receptor Antagonist. (ed. G. N. Tytgat), pp. 10– 19. Theracom, Guildford , U.K . 40 LaBrooy, S.J. (1983) Medical management of gastric ulcer. Annals of the Academy of Medicine (Singapore), 12, 548– 554. 41 Colin-Jones, D.G. (1981) Gastric ulcer short-term healing with cimetidine and other drugs. In: Cimetidine in the Eighties (ed. J. H. Baron) pp. 127– 134. Churchill Livingstone, Edinburgh . 42 Boyd, E.J.S., Wilson, J.A. & Wormsley, K.G. (1982) Maintenance treatment of duodenal and gastric ulcer with ranitidine. In: Ranitidine. Proceedings of an International Symposium (eds. A. J. Riley & P. R. Salmon) pp. 102– 116. Excerpta Medica, Amsterdam . 43 Bardhan, K.D. (1981) Long-term management of duodenal ulcer–a physician's view. In: Cimetidine in the Eighties (ed. J. H. Baron), pp. 95– 112. Churchill Livingstone, Edinburgh . 44 Fry, J. (1964) Peptic ulcer: a profile. British Medical Journal, 2, 809– 812. 45 Sontag, S., Graham, D.Y., Belsito, A. et al. (1984) Cimetidine, cigarette smoking and recurrence of duodenal ulcer. New England Journal of Medicine, 311, 689– 693. 46 Gough, K.R., Bardhan, K.D., Crowe, J.P. et al. (1985) Drinking and smoking when taking H2-antagonists. Lancet, i, 114– 115. 47 Silvis, S.E. (1985) Final report on the United States Multicentre trial comparing ranitidine to cimetidine as maintenance therapy following healing of duodenal ulcer. Journal of Clinical Gastroenterology, 7, 482– 487. 48 Gough, K.R., Bardhan, K.D., Crowe, J.P. et al. (1984) Ranitidine and cimetidine in prevention of duodenal ulcer relapse. Lancet, ii, 659– 662. 49 Santana, I.A., Pounder, R.E., Orchard, K., Wood, E.C., Chronos, N. & Neame, R. (1986) Intragastric acidity during duodenal ulcer maintenance treament with H2-blockers. The Journal of Clinical Nutrition and Gastroenterrology, 1, 122– 126. 50 Machell, R.J. (1981) Gastric ulcer long-term treatment with cimetidine. In: Cimetidine in the Eighties (ed. J. H. Baron), pp. 135– 146. Churchill Livingstone, Edinburgh . 51 Campoli-Richards, D.M. & Clissold, S.P. (1986) Famotidine pharmacodynamics and pharmacokinetic properties and a preliminary review of its therapeutic use in peptic ulcer disease and Zollinger-Ellison syndrome. Drugs, 32, 197– 221. 52 ClissoId, S.P. & Campoli-Richards, D.M. (1986) Omeprazole a preliminary review of its pharmaco-dynamic and pharmacokinetic propertics and Zollinger-Ellison Syndrome. Drugs, 32, 1547. 53 Aenishaenslin, W., Baerlocher, C., Bernoulli, R. et al. (1985) Misoprostol and cimetidine in treatment of duodenal ulcer. Schweizerische Medizinische Wochenschrift, 115, 1225– 1231. 54 Lewis, J.H. (1985) Summary of the 29th meeting of the gastrointestinal drugs advisory committee, food and drug administration. American Journal of Gastroenterology, 80, 743– 745. 55 Lauritsen, K., Staerk Laursen, L., Havelund, T., Bytzer, P., Svendsen, L.B. & Rask-Madsen, J. (1986) Enprostil and ranitidine in duodenal ulcer healing: double-blind comparative trial. British Medical Journal, 292, 864– 866. 56 Walt, R.P., Long, R.G., Logan, R.F.A., Somerville, K.W., Langman, M.J.S. & Hawkey, C.J. (1986) Double-blind clinical trial comparing nocte enprostil with ranitidine in duodenal ulcer. Gastroenterology, 90, 1683. 57 Howden, C.W. & Hunt, R.H. (1986) Enprostil and ranitidine in duodenal ulcer healing. British Medical Journal, 292, 1527– 1528. 58 Collins, P.W. (1986) Development and therapeutic role of synthetic prostaglandins in peptic ulcer disease. Journal of Medicinal Chemistry, 29, 437– 443. 59 Milton-Thompson, G.J. (1982) Monitoring of 24-h acid secretion during antcid treatment. In: Antacids in the Eighties (ed. F. Halter) pp. 72– 75. Urban & Schwarzenberg, Munich . 60 Mahachai, V., Reilly, P. & Thomson, A.B.R. (1985) Comparative effects of pirenzepine and cimetidine, alone and in combination, on 24-hour gastric acidity in duodenal ulcer disease. Clinical Ther apeutics, 7, 98– 111. 61 Sharma, B.K., Walt, R.P., Pounder, R.E., Gomes, M. de F.A., Wood, E.C. & Logan, L.H. (1984) Optimal dose of oral omeprazole for maximal 24 hour decrease of intragastric acidity. Gut, 25, 957– 964. 62 Walt, R.P., Gomes, M. de F.A., Wood, E.C., Logan, L.H. & Pounder, R.E. (1983) Effect of daily oral omeprazole on 24 hour intragastric acidity. British Medical Journal, 287, 12– 14. 63 Santana, I.A., Sharma, B.K., Orchard, K. & Pounder, R.E. (1985) Twenty-four hour intragastric acidity before and during treatment with enprostil. Gut, 26, A545. 64 Deakin, M., Ramage, J.K., Paul, A., Gray, S.P., Billings, J. & Williams, J.G. (1986) Effect of enprostil, a synthetic prostaglandin E2 on 24 hour intragastric acidity, nocturnal and pepsin secretion. Gut, 27, 1054– 1057. 65 Hawkey, C.J. & Walt, R.P. (1986) Prostaglandins for peptic ulcer: a promise unfulfilled. Lancet, ii, 1084– 1087. Volume12, Issue2April 1987Pages 71-80 ReferencesRelatedInformation" @default.
• W2025448304 created "2016-06-24" @default.
• W2025448304 creator A5041630540 @default.
• W2025448304 creator A5062317662 @default.
• W2025448304 date "1987-04-01" @default.
• W2025448304 modified "2023-09-25" @default.
• W2025448304 title "THERAPEUTIC PROGRESS–REVIEW XXIV ARE WE MAKING PROGRESS? THE TREATMENT OF PEPTIC ULCER DISEASE BY CONTROL OF GASTRIC ACIDITY" @default.
• W2025448304 cites W1561568838 @default.
• W2025448304 cites W1971221969 @default.
• W2025448304 cites W1980257276 @default.
• W2025448304 cites W1981406934 @default.
• W2025448304 cites W1983183579 @default.
• W2025448304 cites W1983886816 @default.
• W2025448304 cites W1987998589 @default.
• W2025448304 cites W1991890012 @default.
• W2025448304 cites W2005226112 @default.
• W2025448304 cites W2020350628 @default.
• W2025448304 cites W2022143083 @default.
• W2025448304 cites W2024520058 @default.
• W2025448304 cites W2024931474 @default.
• W2025448304 cites W2026514001 @default.
• W2025448304 cites W2026620385 @default.
• W2025448304 cites W2026683651 @default.
• W2025448304 cites W2026926322 @default.
• W2025448304 cites W2034864833 @default.
• W2025448304 cites W2047770704 @default.
• W2025448304 cites W2058553413 @default.
• W2025448304 cites W2060594132 @default.
• W2025448304 cites W2064044880 @default.
• W2025448304 cites W2072760263 @default.
• W2025448304 cites W2081291192 @default.
• W2025448304 cites W2082627526 @default.
• W2025448304 cites W2088120307 @default.
• W2025448304 cites W2090049591 @default.
• W2025448304 cites W2092981837 @default.
• W2025448304 cites W2105832053 @default.
• W2025448304 cites W2124285328 @default.
• W2025448304 cites W2137426284 @default.
• W2025448304 cites W2145086496 @default.
• W2025448304 cites W2161958363 @default.
• W2025448304 cites W2168275582 @default.
• W2025448304 cites W2434326657 @default.
• W2025448304 cites W2462649304 @default.
• W2025448304 cites W4255226051 @default.
• W2025448304 doi "https://doi.org/10.1111/j.1365-2710.1987.tb00511.x" @default.
• W2025448304 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/3294867" @default.
• W2025448304 hasPublicationYear "1987" @default.
• W2025448304 type Work @default.
• W2025448304 sameAs 2025448304 @default.
• W2025448304 citedByCount "0" @default.
• W2025448304 crossrefType "journal-article" @default.
• W2025448304 hasAuthorship W2025448304A5041630540 @default.
• W2025448304 hasAuthorship W2025448304A5062317662 @default.
• W2025448304 hasBestOaLocation W20254483041 @default.
• W2025448304 hasConcept C126322002 @default.
• W2025448304 hasConcept C177713679 @default.
• W2025448304 hasConcept C2779134260 @default.
• W2025448304 hasConcept C2780656511 @default.
• W2025448304 hasConcept C71924100 @default.
• W2025448304 hasConcept C90924648 @default.
• W2025448304 hasConceptScore W2025448304C126322002 @default.
• W2025448304 hasConceptScore W2025448304C177713679 @default.
• W2025448304 hasConceptScore W2025448304C2779134260 @default.
• W2025448304 hasConceptScore W2025448304C2780656511 @default.
• W2025448304 hasConceptScore W2025448304C71924100 @default.
• W2025448304 hasConceptScore W2025448304C90924648 @default.
• W2025448304 hasIssue "2" @default.
• W2025448304 hasLocation W20254483041 @default.
• W2025448304 hasLocation W20254483042 @default.
• W2025448304 hasOpenAccess W2025448304 @default.
• W2025448304 hasPrimaryLocation W20254483041 @default.
• W2025448304 hasRelatedWork W1980506963 @default.
• W2025448304 hasRelatedWork W2022595123 @default.
• W2025448304 hasRelatedWork W2404025629 @default.
• W2025448304 hasRelatedWork W2406719928 @default.
• W2025448304 hasRelatedWork W2409276078 @default.
• W2025448304 hasRelatedWork W2417582986 @default.
• W2025448304 hasRelatedWork W2441786729 @default.
• W2025448304 hasRelatedWork W2759272483 @default.
• W2025448304 hasRelatedWork W3041679829 @default.
• W2025448304 hasRelatedWork W3200983457 @default.
• W2025448304 hasVolume "12" @default.
• W2025448304 isParatext "false" @default.
• W2025448304 isRetracted "false" @default.
• W2025448304 magId "2025448304" @default.
• W2025448304 workType "article" @default.